Intercept Pharmaceuticals Inc EBITDA margin
Что обозначает EBITDA margin в Intercept Pharmaceuticals Inc?
EBITDA margin Intercept Pharmaceuticals Inc является -29.95%
Какое определение для EBITDA margin?
EBITDA margin is a profitability ratio that measures how much EBITDA the company generates as a percentage of revenue.
ttm (trailing twelve months)
EBITDA margin measures how much of EBITDA is generated as a percentage of sales. It measures the company’s operating profit as a percentage of its revenue and is calculated as EBITDA (earnings before interest, taxes, depreciation, and amortization) divided by total revenue.
EBITDA margin also helps with judging the effectiveness of cost-cutting processes at the company. The higher the company’s EBITDA margin, the lower operating expenses are in respect to revenue. As a result, a higher EBITDA margin is considered more favorable. Smaller companies can have higher EBITDA margins since they are able to operate more efficiently and maximize their profitability.
EBITDA excludes interest on debt, taxes, and capital expenditures, the margin does not provide a perfectly clear estimate of the business’s cash flow generation. Furthermore, EBITDA margin is not recognized as a GAAP (generally accepted accounting principles) metric.
EBITDA margin компаний в Health Care сектор на NASDAQ по сравнению с Intercept Pharmaceuticals Inc
Что делает Intercept Pharmaceuticals Inc?
we are a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive, non-viral liver diseases, including primary biliary cholangitis (pbc), nonalcoholic steatohepatitis (nash), primary sclerosing cholangitis (psc) and biliary atresia. in a new age of liver disease treatment, our team is developing vital therapies to meet the needs of those living with progressive, non-viral liver disease. we are committed to improving patients’ lives and addressing the liver community’s most pressing needs. our corporate headquarters is located in new york, and we have additional offices in san diego, london and perugia. for more information about intercept, please visit our website at: www.interceptpharma.com and follow us on twitter at: @interceptpharma.
Компании с ebitda margin похож на Intercept Pharmaceuticals Inc
- Starcom Plc имеет EBITDA margin из -30.13%
- Aban Offshore имеет EBITDA margin из -30.08%
- Bever NV имеет EBITDA margin из -30.07%
- East 33 Ltd имеет EBITDA margin из -30.02%
- Symphony Environmental Technologies Plc имеет EBITDA margin из -30.00%
- InnoCare Pharma имеет EBITDA margin из -29.99%
- Intercept Pharmaceuticals Inc имеет EBITDA margin из -29.95%
- Jimu имеет EBITDA margin из -29.92%
- Zip Co имеет EBITDA margin из -29.92%
- BlackRock Muni Fund II Inc имеет EBITDA margin из -29.91%
- McEwen Mining имеет EBITDA margin из -29.77%
- K2 Asset Management Ltd имеет EBITDA margin из -29.76%
- Greenrose Acquisition имеет EBITDA margin из -29.72%